Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy

Research output: Contribution to journalLetterResearchpeer-review

View graph of relations
Original languageEnglish
JournalScandinavian Journal of Rheumatology
Volume48
Issue number4
Pages (from-to)342-343
Number of pages2
ISSN0300-9742
DOIs
Publication statusPublished - 2019

    Research areas

  • Aged, Antirheumatic Agents/administration & dosage, Bone Marrow Examination/methods, Dexamethasone/administration & dosage, Fatal Outcome, Humans, Immunoglobulins, Intravenous/administration & dosage, Infliximab/administration & dosage, Leishmaniasis, Visceral/diagnosis, Lymphohistiocytosis, Hemophagocytic/diagnosis, Male, Patient Care Management/methods, Sarcoidosis/drug therapy, Tumor Necrosis Factor-alpha/antagonists & inhibitors

ID: 56689966